Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Use of antioxidant supplements during breast cancer treatment: a comprehensive review
Breast Cancer Research and Treatment, 10/16/08
Greenlee H et al. – Evidence is insufficient to inform clinician and pt guidelines on use of antioxidant supplements during breast cancer treatment; well designed clinical trials and observational studies are needed to determine the short- and long-term effects of such agents
Methods- Comprehensive literature review on association between antioxidant supplement use during breast cancer treatment and pt outcomes
- Inclusion criteria: ≥2 subjects; clinical trial or observational study design; use of antioxidant supplements (vitamin C, vitamin E, antioxidant combinations, multivitamins, glutamine, glutathione, melatonin, or soy isoflavones) during chemotherapy, radiation therapy, and/or hormonal therapy for breast cancer as exposures; treatment toxicities, tumor response, recurrence, or survival as outcomes
- Criteria met by 22 articles
- Findings did not support any conclusions regarding effects of individual antioxidant supplements during conventional breast cancer treatment on toxicities, tumor response, recurrence, or survival
- Antioxidant supplements may decrease side effects associated with treatment, including vitamin E for hot flashes due to hormonal therapy and glutamine for oral mucositis during chemotherapy
- Underpowered trials suggest that melatonin may enhance tumor response during treatment
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer
Supportive Care in Cancer, 12/12/09
Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF-kappaB and Upregulation of TRAIL Receptors
Cancer Research, 12/10/09
Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines
Chemotherapy, 12/09/09
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Life expectancy of screen-detected invasive breast cancer patients compared with women invited to the Nijmegen screening program
Cancer, 12/15/09
Is Green Tea Drinking Associated With a Later Onset of Breast Cancer?
Annals of Epidemiology , 12/15/09
Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines
Cancer Chemotherapy and Pharmacology, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


